quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:15:51·50d
SECFiling
PepGen Inc. logo

SEC Form 10-K filed by PepGen Inc.

PEPG· PepGen Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • PEPG
    PepGen Inc.
    Health Care

Recent analyst ratings

  • Sep 9UpdateGuggenheim$6.00
  • Dec 16UpdateBofA Securities$3.00
  • Jul 31UpdateBofA Securities$12.00
  • Dec 21UpdateH.C. Wainwright$26.00

Related

  • SEC24d
    PepGen Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
  • PR24d
    PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data
  • SEC43d
    SEC Form SCHEDULE 13G filed by PepGen Inc.
  • INSIDER48d
    EVP, Head of R&D Streck Paul sold $11,709 worth of shares (1,879 units at $6.23), decreasing direct ownership by 2% to 76,226 units (SEC Form 4)
  • INSIDER48d
    Chief Financial Officer Donnelly Noel sold $12,988 worth of shares (2,084 units at $6.23), decreasing direct ownership by 2% to 111,603 units (SEC Form 4)
  • INSIDER48d
    President and CEO Mcarthur James G sold $32,876 worth of shares (5,275 units at $6.23), decreasing direct ownership by 2% to 296,326 units (SEC Form 4)
  • SEC50d
    PepGen Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • SEC50d
    SEC Form S-8 filed by PepGen Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022